SureTrader Stock Hero Advertisement SureTrader
Home > Boards > US OTC > Biotechs > Amarantus BioScience Holdings, Inc. (AMBS)

Price target of AMBS at $1.25!! All aboard!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
barbershop Member Profile
Member Level 
Followed By 61
Posts 9,766
Boards Moderated 0
Alias Born 10/26/09
160x600 placeholder
Advertisement
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/22/2015 8:31:09 AM
Amarantus Effects Capital Restructuring in Anticipation of National Exchange Listing "GlobeNewswire Inc." - 5/22/2015 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/21/2015 5:18:06 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/21/2015 9:17:01 AM
Amarantus Enters Into CRO Agreement With Chiltern International to Commence Phase 2b Clinical Development of Eltoprazine in P... "GlobeNewswire Inc." - 5/21/2015 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/20/2015 9:03:03 AM
Amarantus Reports First Quarter 2015 Financial Results and Business Overview "GlobeNewswire Inc." - 5/20/2015 7:05:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/19/2015 5:10:53 PM
Amarantus to Present at Two Upcoming Investor Conferences "GlobeNewswire Inc." - 5/19/2015 7:05:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/15/2015 4:10:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/15/2015 4:08:13 PM
Amarantus Announces Successful Delivery and Distribution of MANF in Preclinical Model to Brain Areas Involved in Parkinson's ... "GlobeNewswire Inc." - 5/15/2015 8:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/14/2015 4:07:22 PM
Amarantus Enters Into cGMP Manufacturing Agreement With Catalent Biologics for Production of MANF for Human Clinical Studies "GlobeNewswire Inc." - 5/14/2015 8:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/13/2015 4:07:02 PM
Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Proprietary Methods of Administration and Composi... "GlobeNewswire Inc." - 5/13/2015 1:00:00 PM
Four Companies Moving Forward in Growth Mode "InvestorsHub NewsWire" - 5/13/2015 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/11/2015 4:07:14 PM
IPOs & Transactions Week in Review: May 4 - 8 "PR Newswire (US)" - 5/11/2015 10:18:00 AM
Amarantus Reports Preliminary Data From Blood-based Version of MSPrecise(R) Diagnostic for Multiple Sclerosis "GlobeNewswire Inc." - 5/11/2015 8:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/8/2015 4:08:50 PM
Amarantus Announces the Presentation of Data Showing MANF's Positive Effect on Retinal Function at Association for Research i... "GlobeNewswire Inc." - 5/7/2015 11:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/5/2015 9:06:55 AM
Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Proprietary Compositions of Matter and Methods of... "GlobeNewswire Inc." - 5/5/2015 8:05:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 5/4/2015 5:19:23 PM
barbershop Member Level  Wednesday, 12/26/12 08:08:01 AM
Re: fouraces post# 26607
Post # of 114589 
Price target of AMBS at $1.25!! All aboard!! Wow. Talk about a positive investor note. Abbot is a huge player. Monster.

By reading this or any of my posts, you are accepting the sole responsibility for your own investment decisions. Never buy any stock based on what is posted above. Due your own DD.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist